| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 76, 399-403, Copyright © 1993 by Endocrine Society
ARTICLES |
DL Eizirik, N Welsh and C Hellerstrom
Department of Medical Cell Biology, Uppsala University, Sweden.
The aim of the present study was to characterize the effects of human recombinant interleukin-1 beta (rIL-1 beta) on human pancreatic islets. For this purpose, islets isolated from adult cadaveric donors were exposed to rIL-1 beta (1 or 3 ng/mL) for different periods of time. In some experiments, rat pancreatic islets were exposed in parallel to the cytokine. After 48 h of culture in the presence of rIL-1 beta, the human islets showed an increased insulin release during short term incubations in the presence of 1.7 or 16.7 mM glucose. There was also a 3- to 4-fold increase in insulin accumulation into the culture medium, but rIL-1 beta did not affect human islet glucose metabolism. These stimulatory effects of rIL-1 beta on human islets were already present after an acute (2-h) exposure to the cytokine, and this functional stimulation was blocked by an IL-1 receptor antagonist protein. After exposure of human islets to rIL-1 beta for 6 days, there was no effect of the cytokine on either glucose metabolism or insulin release compared to those in control islets. Rat islets exposed for 48 h in culture to the same concentrations of rIL-1 beta, however, showed a 40- 60% decrease in insulin accumulation into the medium, glucose-induced insulin release, and glucose oxidation. Moreover, while there was no effect of rIL-1 beta on nitrite production by human islets, there was a 7- to 11-fold increase in nitrite production by rat islets. Nitrite is an end product of the highly reactive radical nitric oxide (NO), and there are data to suggest that NO is an important mediator of the suppressive and cytotoxic actions of IL-1 on rat islets. The present observations suggest that human islets are less sensitive to the inhibitory effects of human rIL-1 beta than rat islets, and that this is due to a lack of induction of NO synthesis by the cytokine in human islet cells.
This article has been cited by other articles:
![]() |
J. D. Veldhuis, D. M. Keenan, and S. M. Pincus Motivations and Methods for Analyzing Pulsatile Hormone Secretion Endocr. Rev., December 1, 2008; 29(7): 823 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Z. Khaldi, H. Elouil, Y. Guiot, J. C. Henquin, and J. C. Jonas Antioxidants N-acetyl-L-cysteine and manganese(III)tetrakis (4-benzoic acid)porphyrin do not prevent beta-cell dysfunction in rat islets cultured in high glucose for 1 wk Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E137 - E146. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Welsh, M. Cnop, I. Kharroubi, M. Bugliani, R. Lupi, P. Marchetti, and D. L. Eizirik Is There a Role for Locally Produced Interleukin-1 in the Deleterious Effects of High Glucose or the Type 2 Diabetes Milieu to Human Pancreatic Islets? Diabetes, November 1, 2005; 54(11): 3238 - 3244. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chen, X. Li, and P. N. Epstein MnSOD and Catalase Transgenes Demonstrate That Protection of Islets From Oxidative Stress Does Not Alter Cytokine Toxicity Diabetes, May 1, 2005; 54(5): 1437 - 1446. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Sherrard Manipulating the Calcium Receptor J. Am. Soc. Nephrol., April 1, 2002; 13(4): 1124 - 1125. [Full Text] [PDF] |
||||
![]() |
M.-C. Chen, V. Paez-Espinosa, N. Welsh, and D. L. Eizirik Interleukin-1{beta} Regulates Phospholipase D-1 Expression in Rat Pancreatic {beta}-Cells Endocrinology, August 1, 2000; 141(8): 2822 - 2828. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Pincus, M. L. Hartman, F. Roelfsema, M. O. Thorner, and J. D. Veldhuis Hormone pulsatility discrimination via coarse and short time sampling Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E948 - E957. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Flodstrom and D. L. Eizirik Interferon-{gamma}-Induced Interferon Regulatory Factor-1 (IRF-1) Expression in Rodent and Human Islet Cells Precedes Nitric Oxide Production Endocrinology, July 1, 1997; 138(7): 2747 - 2753. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Delaney, D. Pavlovic, A. Hoorens, D. G. Pipeleers, and D. L. Eizirik Cytokines Induce Deoxyribonucleic Acid Strand Breaks and Apoptosis in Human Pancreatic Islet Cells Endocrinology, June 1, 1997; 138(6): 2610 - 2614. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Veldhuis, A. Iranmanesh, E. Samojlik, and R. J. Urban Differential Sex Steroid Negative Feedback Regulation of Pulsatile Follicle-Stimulating Hormone Secretion in Healthy Older Men: Deconvolution Analysis and Steady- State Sex-Steroid Hormone Infusions in Frequently Sampled Healthy Older Individuals J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1248 - 1254. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tillmar, C. Carlsson, and N. Welsh Control of Insulin mRNA Stability in Rat Pancreatic Islets. REGULATORY ROLE OF A 3'-UNTRANSLATED REGION PYRIMIDINE-RICH SEQUENCE J. Biol. Chem., January 4, 2002; 277(2): 1099 - 1106. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |